Find Explosive Growth Stocks With William O'Neil's CAN SLIM® Methodology

3 mins read

The CAN SLIM® methodology, developed by legendary investor William O’Neil, has been the gold standard for identifying high-growth stocks for decades. O’Neil’s career took off with a 4,000% return in one year, and his book How to Make Money in Stocks has sold over 4 million copies. If you’re serious about finding explosive growth opportunities, The CANSLIM scan is your go-to tool for applying these time-tested principles. Here’s everything you need to know.

Find Explosive Growth Stocks With CANSLIM

What Is CANSLIM?

CAN SLIM is a powerful framework that merges both technical and fundamental analysis, guiding traders and investors toward stocks with explosive growth potential. The acronym CAN SLIM stands for:

C – 25% YoY EPS growth in the most recent quarter.
A – 25% YoY EPS growth in at least one quarter a year for three years in a row.
N – Price is currently within 15% of the 52-week high.
S – Average monthly volume is increasing.
L – Currently outperforming at least 80% of the S&P 500.
I – Analyst buy rating within the last 90 days.
M – Price is above a rising 200-day SMA.

The CANSLIM Scan

We offer two versions of The CANSLIM Scan that you can add to your account using the links below. The version on the left focuses on large caps, scanning through the NYSE composite list, while the version on the right targets small-cap names in the Russell 2000 that currently meet the CAN SLIM criteria.

"The CANSLIM Scan #smallcaps" scanner by TrendSpider

Powered by tools like Analyst Estimates and Relative Performance, The CANSLIM Scan zeroes in on the stocks with the highest growth potential, putting you in a prime position to capitalize. You can seamlessly import the scan into your TrendSpider account and start filtering the market for these top performers immediately.

This is an image of all the criteria that make up the canslim scan.

Today’s CANSLIM Names

The CANSLIM scan is designed to be highly selective, filtering out any companies with underlying weaknesses. As a result, only a few elite stocks meet these rigorous criteria. Right now, the scan has identified some standout performers—let’s take a closer look at these top candidates.

PLTR (Palantir)

Palantir Technologies has been on a tear since its inclusion into the S&P 500 at the end of September. The company has posted an impressive 8 consecutive quarters of year-over-year earnings growth, each exceeding 100%, and is currently outperforming 99.6% of names in the S&P 500. Now trading at all-time highs, the stock has gained a whopping 247% year-to-date, prompting analysts from Argus Research and Jefferies to suggest it might be time to pump the brakes with their recent issuance of hold and sell downgrades.

This is a image of several different PLTR charts, including two price charts, one with its EPS numbers and one with its relative performance value. Additionally, you can see recent analyst estimates and earnings numbers below.

HIMS (Hims & Hers Health, Inc)

Among the names currently appearing in the scan, Hims & Hers Health, Inc. stands out with impressive earnings results in the most recent quarter, outpacing the same quarter in the previous year by over 1,000%. This performance has driven the stock’s year-to-date return past 200%, and with fresh all-time highs made just this week, it looks like the move could be just getting started. The only problem? The stock is currently trading above the analyst consensus price target. So, will the street have to reassess, or do they know something we don’t?

This is a image of several different HIMS charts, including two price charts, one with its EPS numbers and one with its relative performance value. Additionally, you can see recent analyst estimates and earnings numbers below.

HWM (Howmet Aerospace Inc.)

Howmet Aerospace, known for its high-performance metal products used in aerospace and transportation, has been on a remarkable run. Not only is it up over 113% this year, but it’s also outperforming an impressive 97.2% of the S&P 500. With 11 straight quarters of year-over-year earnings growth, Howmet’s consistent performance hasn’t gone unnoticed—recent buy ratings from Baird, RBC Capital, UBS, and others, along with an average price target of $132, suggest that the street believes this name still has a bit more juice left before this run is over.

This is a image of several different HWM charts, including two price charts, one with its EPS numbers and one with its relative performance value. Additionally, you can see recent analyst estimates and earnings numbers below.

High Growth Stocks Delivered Direct To Your Inbox

To stay ahead in the market, timely data is crucial. The CANSLIM Scan helps you quickly identify explosive growth stocks, but the list is ever-changing. Scheduled Scanning ensures you efficiently track changes as new names appear and others drop off, saving you time while keeping you up-to-date with the latest market movers.